You are here

Galleri

Grail Expands Blood Test to Symptomatic Patients, Aims to Revolutionize Cancer Diagnosis

BioSpace

Sun, 06/4/23 - 04:21 pm

Esmo 2022 – Galleri’s real-world exhibition disappoints

EP Vantage

Fri, 09/9/22 - 10:39 am

multi-cancer test

Prepping for FDA approval, Grail is partnering with health systems to validate its pan-cancer test

MedCity News

Thu, 06/16/22 - 11:01 pm

pan cancer test

With Illumina Acquisition Pending, GRAIL Presents Multi-Cancer Detection Test

BioSpace

Mon, 06/7/21 - 08:32 pm

clinical trials